All the latest news relating to paedatric oncology and adolescents and young adults with cancer
NICE recommends dabrafenib plus trametinib combo for treating BRAF V600E mutation-positive brain tumours
Novartis announced today that the National Institute for Health and Care Excellence has published its Final Draft…